All In MedTech

Device Trial Radar · NCT06701461

Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Aug 2026

Primary completion

Sep 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Dartmouth-Hitchcock Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Connecticut
First posted
Nov 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 50 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale studies.

Conditions

  • Osteo Arthritis Knee

Interventions

  • Electrodermal Activity signalDevice

    Determining if the electrodermal activity signals, as measured by the Embrace Plus smartwatch) can be used to measure osteoarthritic patient pain levels.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. :Difference in pain measurements as reported by the participant via a visual analogue scale versus smartwatch reported electrodermal activity sensorsTime frame: 40 minutes of test time, occurring all in one day.
  2. Patient-reported pain during standardized Osteoarthritis Research Society International (OARSI) 30-second chair testTime frame: 5 minutes
  3. Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) 30-second chair testTime frame: 0 minutes. Concurrent with measurement of patient-reported pain.

7 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.